Worth Noting 5-Amino-1MQ targets an enzyme in fat cells rather than working through hormonal, receptor, or neurotransmitter pathways making it mechanistically different from every other metabolic compound available
This process consumes cellular methyl donors and, critically, prevents nicotinamide from being recycled into NAD+
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
Unlock weight loss potential with 5-Amino-1MQ 5-Amino-1MQ is emerging as a game-changer in weight loss and metabolic health
Research shows that individuals carrying more body fat often experience more dramatic absolute changes in measurements and weight
But it also means that small measurement errors translate to larger dosing mistakes
